SLNO is no longer listed. Its last trade on record was May 18, 2026. The price and figures on this page are from its last trading day and final filings, and are no longer updated.
| 122.46% |
| +0.26 pp |
| $3.78B |
| +65% |
| Q4 2024 | 161 | +16% | 122.20% | +6.33 pp | $2.29B | 2.0% |
| Q3 2024 | 139 | β | 115.87% | β | $2.33B | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
0 institutions opened new positions in SLNO during Q2 2026, while 227 fully exited. 0 added to existing positions and 0 trimmed.
SLNO institutional ownership fell by 126.37 percentage points quarter-over-quarter, with a net change of -230 holders.
The top 10 institutions account for 100.0% of all reported 13F value in SLNO, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Soleno Therapeutics, Inc. (SLNO) Institutional Ownership